Explore more Articles in

BioTech

Weekly Market Outlook: Key Moves in Gold, EUR/USD, and USD/JPY

Global financial markets are entering a crucial week loaded with high-impact macroeconomic developments and policy events that could redefine short-term trends across currencies, commodities,...

Trump’s New Tariffs Shake Markets as Yen and ETFs Slide – iShares MSCI Japan Index Fund (ARCA:EWJ), iShares MSCI Malaysia Index Fund (ARCA:EWM)

The U.S. dollar is notching its strongest one-day gain against the Japanese yen in nearly two months as traders react to President Donald Trump's...

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk of the “death of U.S. exceptionalism.” Early 2025 saw a sharp shift in...

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on Monday, plummeting by nearly 55%. This significant drop is accompanied by an exceptionally...
BioTech

Madrigal’s Fatty Liver Disease Drug Gets Recommendation – Madrigal Pharmaceuticals (NASDAQ:MDGL)

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted on Friday a positive opinion recommending approval for...
BioTech

Capricor Reports 4-Year Data For Deramiocel, Shows Sustained Benefit In Duchenne Patients – Capricor Therapeutics (NASDAQ:CAPR)

Capricor Therapeutics CAPR on Friday released four-year safety and efficacy results from its ongoing HOPE-2 Open-Label Extension (OLE) study of Deramiocel, the company’s lead...
BioTech

Obesity Drugs Help With Weight Loss But Are Adding Fat Elsewhere – Eli Lilly (NYSE:LLY)

A surge in demand for weight-loss and diabetes medications, paired with fears of incoming tariffs, has propelled Ireland to the center of a pharmaceutical...
BioTech

Analyst Downgrades Sarepta As Elevidys Safety Clouds Future Demand – Sarepta Therapeutics (NASDAQ:SRPT)

Earlier this week, Sarepta Therapeutics, Inc SRPT provided a safety update regarding Elevidys (delandistrogene moxeparvovec-rokl), the only approved gene therapy for patients with Duchenne...
BioTech

GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule – GH Research (NASDAQ:GHRS)

DUBLIN, June 20, 2025 (GLOBE NEWSWIRE) -- GH Research PLC GHRS, a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients...
BioTech

FDA Approves Regeneron Sanofi Treatment For Rare Autoimmune Skin Disorder – Regeneron Pharmaceuticals (NASDAQ:REGN), Sanofi (NASDAQ:SNY)

The U.S. Food and Drug Administration (FDA) on Friday approved Regeneron Pharmaceuticals Inc. REGN and Sanofi SA’s SNY Dupixent (dupilumab) for adult patients with bullous pemphigoid...
1...131415...18Page 14 of 18

- A word from our sponsors -

Most Popular

Disclaimer: The content provided is for informational purposes only. We aim to keep the content current and accurate by updating it frequently. Sometimes the actual data can differ from what's stated on our website. Buttonwoodnews.com is an independent platform. While we are independent, we may be compensated for advertisements, sponsored products, or when you click on a link on our website. The contributors and authors are not registered or certified financial advisors. You should consult a financial professional before making any financial decisions.

Copyright © Button Wood News.